About Hosp Provincial D. Centenarios; Oncology Dept
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
3
Genentech, Inc.
1
Clinical Trials at Hosp Provincial D. Centenarios; Oncology Dept
During the past decade, Hosp Provincial D. Centenarios; Oncology Dept conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Evaluate Pertuzumab + Trastuzumab + Docetaxel vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-Positive Metastatic Breast Cancer
2008-02-12
2018-11-23
Completed
808
A Study to Evaluate Safety and Effectiveness of Bevacizumab in Combination With Paclitaxel and Cisplatin/Carboplatin or Toptecan in Participants With Advanced Cervical Cancer
2017-04-06
2017-12-20
Completed
84
A Study of Ipatasertib in Combination With Paclitaxel as a Treatment for Participants With PIK3CA/AKT1/PTEN-Altered, Locally Advanced or Metastatic, Triple-Negative Breast Cancer or Hormone Receptor-Positive, HER2-Negative Breast Cancer
2018-01-06
2023-01-04
Completed
580
A Study Evaluating the Efficacy and Safety of Giredestrant Compared With Physician's Choice of Endocrine Monotherapy in Participants With Previously Treated Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (acelERA Breast Cancer)
2020-11-27
2023-11-27
Active, not recruiting
303
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Hosp Provincial D. Centenarios; Oncology Dept"
#1 collaborator was "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Hosp Provincial D. Centenarios; Oncology Dept
According to Clinical.Site data, the most researched conditions in "Hosp Provincial D. Centenarios; Oncology Dept" are
"Breast Cancer" (1 trials), "Cervical Cancer" (1 trials), "Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer" (1 trials) and "Metastatic Breast Cancer" (1 trials). Many other conditions were trialed in "Hosp Provincial D. Centenarios; Oncology Dept" in a lesser frequency.
Clinical Trials Intervention Types at Hosp Provincial D. Centenarios; Oncology Dept
Most popular intervention types in "Hosp Provincial D. Centenarios; Oncology Dept" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "Docetaxel" (1 trials), "Fulvestrant or an Aromatase Inhibitor (Physician Choice)" (1 trials), "Giredestrant" (1 trials) and "Ipatasertib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hosp Provincial D. Centenarios; Oncology Dept
The vast majority of trials in "Hosp Provincial D. Centenarios; Oncology Dept" are
3 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Hosp Provincial D. Centenarios; Oncology Dept
Currently, there are NaN active trials in "Hosp Provincial D. Centenarios; Oncology Dept".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Hosp Provincial D. Centenarios; Oncology Dept,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Hosp Provincial D. Centenarios; Oncology Dept, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".